Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
about
Autologous Cells for Kidney BioengineeringEvaluation of allowable time and histopathological changes in warm ischemia of the uterus in cynomolgus monkey as a model for uterus transplantation.Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion InjuryStem cell death and survival in heart regeneration and repair.Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response Against Myocardial Infarction via Paracrine Effects.Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy.Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study.Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties.Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1.Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in ratsRecent Advances in Stem Cell-Based Therapeutics for Stroke.Mesenchymal stem cell conditioned medium alleviates oxidative stress injury induced by hydrogen peroxide via regulating miR143 and its target protein in hepatocytes.Stem cell therapy in necrotizing enterocolitis: Current state and future directions.Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury in rats.Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells.Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice.Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.
P2860
Q26740036-39B105C7-0886-493C-8902-26318AB144EFQ36058389-CC6A1201-E0D0-46A2-AA82-64501B111273Q36140947-F013A567-538E-4A40-A499-3EB85AB0EFF0Q37545373-79A26CE1-164A-4ED3-B074-8665D04041C8Q38615599-6530171F-86DD-4D79-9B94-7FC91A513CA3Q39864426-E780B8BD-2C9B-4680-9AC7-A2F02BA59EADQ40979801-2B394C56-27AF-475E-A21F-30576B1CAA72Q41078616-8B361C82-8B19-4C28-940B-373A5A348C06Q41110512-E98806CB-7803-4899-8200-FCF73C7B8D77Q41447058-EDF1C697-0CBD-4BE2-8FDC-810D46DFC068Q44836823-B84F57FC-DF62-4D99-BD8A-766E886D9F25Q47132544-6B40317E-6DAD-4162-8EBF-9424413CADE3Q47765179-2A5DF0D5-44DB-4ADB-A760-BB7CE0B80A64Q48095399-4C396166-B5AC-4A15-87A3-8E3B7344F0FDQ48218622-A83C0503-05CB-43E0-A099-78144D815FDEQ48337519-3FA95A7C-DE4C-4489-B507-3C8ADA9F6351Q50117414-00686B93-7B6C-4066-B86D-B154F1EA6BA1Q54979810-87185A6F-E0EE-45DA-B6A1-86DB7FA4E6A7Q55401793-DA4A4128-03C7-40FA-97AC-344BB7B65330
P2860
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@ast
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@en
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@nl
type
label
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@ast
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@en
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@nl
prefLabel
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@ast
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@en
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
@en
P2093
Alexandra Briquet
Chantal Lechanteur
Céline Grégoire
François Jouret
Jean-Marie Krzesinski
Pauline Erpicum
Yves Beguin
P2860
P304
P3181
P356
10.1155/2015/602597
P407
P577
2015-07-15T00:00:00Z